LD Pensions logo

LD Pensions

Europe, Nordjylland, Denmark, Aalborg

Description

LD Pensions is managing both the Employees 'Holiday Resources and the Employees' Expensive Resources.

Investor Profile

LD Pensions has made 16 investments, with 0 in the past 12 months and 19% as lead.

Stage Focus

  • Series Unknown (25%)
  • Series C (25%)
  • Series B (25%)
  • Series D (13%)
  • Series F (6%)
  • Series A (6%)

Country Focus

  • United States (56%)
  • Denmark (44%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Hospital
  • Medical Device
  • Biopharma
  • Therapeutics
  • Neuroscience
  • Genetics
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does LD Pensions frequently co-invest with?

Vaekstfonden
Europe, Hovedstaden, Denmark, Hellerup
Co-Investments: 2
DKA Capital
Europe, Hovedstaden, Denmark, Copenhagen
Co-Investments: 4
Index Ventures
North America, California, United States, San Francisco
Co-Investments: 2
Essex Woodlands Healthcare Partners
North America, California, United States, Palo Alto
Co-Investments: 2
Johnson & Johnson Development Corporation
North America, New Jersey, United States, New Brunswick
Co-Investments: 2
Karolinska
Europe, Stockholms Lan, Sweden, Solna
Co-Investments: 1
Novo Holdings
Europe, Hovedstaden, Denmark, Hellerup
Co-Investments: 2
Alta Partners
North America, Mississippi, United States, Jackson
Co-Investments: 2
SLS Venture
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 8
BankInvest
Europe, Hovedstaden, Denmark, Copenhagen
Co-Investments: 2

What are some of recent deals done by LD Pensions?

AdvanDx

Woburn, Massachusetts, United States

AdvanDx is a biotech company offering molecular vitro diagnostic kits for the identification and prevention of infectious diseases.

BiotechnologyHealth CareHospitalMedical Device
Series UnknownApr 8, 2014
Amount Raised: $12,000,000
AdvanDx

Woburn, Massachusetts, United States

AdvanDx is a biotech company offering molecular vitro diagnostic kits for the identification and prevention of infectious diseases.

BiotechnologyHealth CareHospitalMedical Device
Series COct 12, 2009
Amount Raised: $8,000,000
7TM Pharma

Lyngby, Hovedstaden, Denmark

7TM Pharma is a biotech company that discovers and develops drugs with a primary therapeutic focus on diabetes, asthma, and more.

BiotechnologyHealth CareTherapeutics
Series UnknownJan 15, 2009
Amount Raised: $15,000,000
AdvanDx

Woburn, Massachusetts, United States

AdvanDx is a biotech company offering molecular vitro diagnostic kits for the identification and prevention of infectious diseases.

BiotechnologyHealth CareHospitalMedical Device
Series CSep 18, 2007
Amount Raised: $15,000,000
AdvanDx

Woburn, Massachusetts, United States

AdvanDx is a biotech company offering molecular vitro diagnostic kits for the identification and prevention of infectious diseases.

BiotechnologyHealth CareHospitalMedical Device
Series BMay 8, 2006
Amount Raised: $5,000,000
7TM Pharma

Lyngby, Hovedstaden, Denmark

7TM Pharma is a biotech company that discovers and develops drugs with a primary therapeutic focus on diabetes, asthma, and more.

BiotechnologyHealth CareTherapeutics
Series CMar 31, 2006
Amount Raised: $23,029,661
Symphogen

Lyngby, Hovedstaden, Denmark

Symphogen is a biotechnology company that produces recombinant polyclonal antibody drugs for disease treatment and prevention.

BiopharmaBiotechnologyPharmaceutical
Series DJan 10, 2006
Amount Raised: $25,000,000
Exiqon

Vedbæk, Hovedstaden, Denmark

Exiqon operates in two business areas, Life Sciences and Diagnostics.

BiotechnologyGeneticsHealth CareHealth DiagnosticsLife ScienceMedical
Series UnknownJun 3, 2005
Amount Raised: $20,000,000
NsGene

Ballerup, Hovedstaden, Denmark

NsGene develops products for the treatment of neurological, alzheimer’s, and parkinson's disease and sensorineural hearing loss.

BiopharmaBiotechnologyNeuroscience
Series UnknownMay 2, 2005
Amount Raised: $5,140,000
Symphogen

Lyngby, Hovedstaden, Denmark

Symphogen is a biotechnology company that produces recombinant polyclonal antibody drugs for disease treatment and prevention.

BiopharmaBiotechnologyPharmaceutical
Series CNov 5, 2004
Amount Raised: $25,000,000